PERBEDAAN KADAR HEMOGLOBIN PADA PENDERITA TUBERKULOSIS SEBELUM PENGOBATAN, SESUDAH PENGOBATAN FASE INTENSIF DAN AKHIR PENGOBATAN DI FASYANKES KECAMATAN PRACIMANTORO

Yuliasih, Andriani (2022) PERBEDAAN KADAR HEMOGLOBIN PADA PENDERITA TUBERKULOSIS SEBELUM PENGOBATAN, SESUDAH PENGOBATAN FASE INTENSIF DAN AKHIR PENGOBATAN DI FASYANKES KECAMATAN PRACIMANTORO. Other thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Yuliasih Andriani.pdf Restricted to Repository staff only Download (2MB)
	Text Intisari&Abstract.pdf Download (49kB)

Abstract

Tuberculosis (TB) is caused by the bacterium Mycobacterium tuberculosis and most commonly attacks the lungs. This disease is a public health problem throughout the world, especially in countries with tropical and subtropical climates and has high rainfall. Treatment of tuberculosis is with anti-tuberculosis drugs (OAT) including isoniazid, rifampicin, ethambutanol, strep-thomacin, and pyrazinamide which are acceptable in therapy, but have potential effects including side effects of hematological reactions, one of which is hemoglobin. The purpose of this study was to determine the difference in hemoglobin levels in patients with tuberculosis before treatment and after treatment in the intensive and final phases of treatment with OAT administration in the health facilities of Pracimantoro District. This research is an analytical study with an observational approach with a cross sectional design, using research subjects as many as 30 tuberculosis respondents who underwent anti-tuberculosis drug therapy at Pracimantoro Health Center 1. Data were collected by examining Hb with Hematology Analyzer Sysmex Poch 100i. The results showed that the ANOVA analysis obtained a sign value of 0.044 < (0.05). Based on the hypothesis that has been written, the results are H0 is rejected and Ha is accepted. The conclusion is that there is a significant difference between hemoglobin levels in tuberculosis patients before treatment, after the intensive phase of treatment and at the end of treatment at Pracimantoro Health Center.

Actions (login required)

View Item